טוען...
Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy
No effective treatment for COVID-19 has been well established yet. Nafamostat, known as anticoagulant, has potential anti-inflammatory and anti-viral activities against COVID-19. We report three cases of COVID-19 pneumonia who progressed while using antiviral drugs and needed supplementary oxygen th...
שמור ב:
| הוצא לאור ב: | Int J Infect Dis |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7250091/ https://ncbi.nlm.nih.gov/pubmed/32470602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijid.2020.05.072 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|